Literature DB >> 26998397

Liver Cell Culture Devices.

B Andria1, A Bracco2, G Cirino3, R A F M Chamuleau4.   

Abstract

In the last 15 years many different liver cell culture devices, consisting of functional liver cells and artificial materials, have been developed. They have been devised for numerous different applications, such as temporary organ replacement (a bridge to liver transplantation or native liver regeneration) and as in vitro screening systems in the early stages of the drug development process, like assessing hepatotoxicity, hepatic drug metabolism, and induction/inhibition studies. Relevant literature is summarized about artificial human liver cell culture systems by scrutinizing PubMed from 2003 to 2009. Existing devices are divided in 2D configurations (e.g., static monolayer, sandwich, perfused cells, and flat plate) and 3D configurations (e.g., liver slices, spheroids, and different types of bioreactors). The essential features of an ideal liver cell culture system are discussed: different types of scaffolds, oxygenation systems, extracellular matrixes (natural and artificial), cocultures with nonparenchymal cells, and the role of shear stress problems. Finally, miniaturization and high-throughput systems are discussed. All these factors contribute in their own way to the viability and functionality of liver cells in culture. Depending on the aim for which they are designed, several good systems are available for predicting hepatotoxicity and hepatic metabolism within the general population. To predict hepatotoxicity in individual cases genomic analysis might be essential as well.

Entities:  

Keywords:  Bioreactor; Cell culture devices; Drug delivery; Human liver cells

Year:  2010        PMID: 26998397      PMCID: PMC4789323          DOI: 10.3727/215517910X519274

Source DB:  PubMed          Journal:  Cell Med        ISSN: 2155-1790


  110 in total

1.  Novel approach for achieving double-layered cell sheets co-culture: overlaying endothelial cell sheets onto monolayer hepatocytes utilizing temperature-responsive culture dishes.

Authors:  Masami Harimoto; Masayuki Yamato; Motohiro Hirose; Chie Takahashi; Yuki Isoi; Akihiko Kikuchi; Teruo Okano
Journal:  J Biomed Mater Res       Date:  2002-12-05

2.  Construction and performance of a minibioreactor suitable as experimental bioartificial liver.

Authors:  Joaquín V Rodriguez; María Dolores Pizarro; Angel L Scandizzi; Edgardo E Guibert; Luciana L Almada; María E Mamprin
Journal:  Artif Organs       Date:  2008-04       Impact factor: 3.094

3.  Pilot-controlled trial of the extracorporeal liver assist device in acute liver failure.

Authors:  A J Ellis; R D Hughes; J A Wendon; J Dunne; P G Langley; J H Kelly; G T Gislason; N L Sussman; R Williams
Journal:  Hepatology       Date:  1996-12       Impact factor: 17.425

4.  In vitro zonation and toxicity in a hepatocyte bioreactor.

Authors:  Jared W Allen; Salman R Khetani; Sangeeta N Bhatia
Journal:  Toxicol Sci       Date:  2004-12-08       Impact factor: 4.849

5.  Maintenance and reversibility of active albumin secretion by adult rat hepatocytes co-cultured with another liver epithelial cell type.

Authors:  C Guguen-Guillouzo; B Clément; G Baffet; C Beaumont; E Morel-Chany; D Glaise; A Guillouzo
Journal:  Exp Cell Res       Date:  1983-01       Impact factor: 3.905

6.  Modular extracorporeal liver support.

Authors:  Igor M Sauer; Joerg C Gerlach
Journal:  Artif Organs       Date:  2002-08       Impact factor: 3.094

7.  Functional and morphological comparison of three primary liver cell types cultured in the AMC bioartificial liver.

Authors:  Paul P C Poyck; Ruurdtje Hoekstra; Albert C W A van Wijk; Chiara Attanasio; Fulvio Calise; Robert A F M Chamuleau; Thomas M van Gulik
Journal:  Liver Transpl       Date:  2007-04       Impact factor: 5.799

8.  Significant contribution of liver nonparenchymal cells to metabolism of ammonia and lactate and cocultivation augments the functions of a bioartificial liver.

Authors:  Geir I Nedredal; Kjetil Elvevold; Lars M Ytrebø; Ole-Martin Fuskevåg; Ingvild Pettersen; Kjell Bertheussen; Bodil Langbakk; Bård Smedsrød; Arthur Revhaug
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2007-03-15       Impact factor: 4.052

9.  Evaluation of drug-metabolizing and functional competence of human hepatocytes incubated under hypothermia in different media for clinical infusion.

Authors:  María José Gómez-Lechón; Agustín Lahoz; Nuria Jiménez; Ana Bonora; José V Castell; María Teresa Donato
Journal:  Cell Transplant       Date:  2008       Impact factor: 4.064

10.  Evaluation of a microfluidic based cell culture platform with primary human hepatocytes for the prediction of hepatic clearance in human.

Authors:  P Chao; T Maguire; E Novik; K-C Cheng; M L Yarmush
Journal:  Biochem Pharmacol       Date:  2009-05-20       Impact factor: 5.858

View more
  2 in total

Review 1.  Preclinical models of idiosyncratic drug-induced liver injury (iDILI): Moving towards prediction.

Authors:  Antonio Segovia-Zafra; Daniel E Di Zeo-Sánchez; Carlos López-Gómez; Zeus Pérez-Valdés; Eduardo García-Fuentes; Raúl J Andrade; M Isabel Lucena; Marina Villanueva-Paz
Journal:  Acta Pharm Sin B       Date:  2021-11-18       Impact factor: 11.413

Review 2.  New Perspectives in Liver Transplantation: From Regeneration to Bioengineering.

Authors:  Debora Bizzaro; Francesco Paolo Russo; Patrizia Burra
Journal:  Bioengineering (Basel)       Date:  2019-09-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.